Carprodyl Quadri

10 x 10 pc

Tablet

Active substance

Carprofen : 50 mg

ATC code

QM01AE91 Carprofen

QM01AE Propionic acid derivatives

QM01A Antiinflammatory and antirheumatic products, non-steroids (NSAIDs)

QM01 Antiinflammatory and antirheumatic products

QM Musculo-skeletal system

Species

Dogs

Indications

Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease.

As a follow-up to parenteral analgesia in the management of post-operative pain.

Dose to be administered and administration route

For oral administration.

4 mg carprofen per kg bodyweight per day.

An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose. The analgesic effect from each dose persists for at least 12 hours.

The daily dose may be reduced, subject to clinical response.

Duration of treatment will be dependant upon the response seen. Long term treatment should be under regular veterinary supervision.

To extend analgesic and anti-inflammatory cover post-operatively parenteral pre- operative treatment with an injectable carprofen may be followed with carprofen tablets at 4 mg/kg/day for 5 days. Do not exceed the stated dose.

The breakability method is the following: Put the tablet on a plain surface, with its scored side facing the surface (convex face up).

With the tip of forefinger, exert a slight vertical pressure on the middle of the tablet to break it in its width into halves. In order to obtain quarters, then exert a slight pressure on the middle of one half with forefinger to break it in its length.

The tablet is divisible and can be used as follows:

Number of tablets per day	Dog weight (kg)
¼	> 3 -	< 6
½	≥ 6 -	< 9
¾	≥ 9 -	< 12.5
1	≥ 12.5 -	< 15.5
1 ¼	≥ 15.5 -	< 18.5
1 ½	≥ 18.5 -	< 21.5
1 ¾	≥ 21.5 -	< 25
2	≥ 25 -	< 28
2 ¼	≥ 28 -	< 31
2 ½	≥ 31 -	< 34
2 ¾	≥ 34 -	< 37
3	≥ 37 -	< 40
3 ¼	≥ 40 -	< 43
3 ½	≥ 43 -	< 45

The tablets are flavoured, and are accepted by dogs, but they may be administered directly in the mouth of the dog or added to food if necessary.

Adverse reactions

Dog

Rare

(1 to 10 animals / 10,000 animals treated):

Renal disorder ^{^[1]}

Hepatic disorder^1,3

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Vomiting^{^[2]}, Soft stool/Diarrhoea², Blood in faeces ²

Appetite loss², Lethargy²

¹As with other NSAIDs

²Typical undesirable effects associated with NSAIDs, these adverse reactions generally occur within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases maybe serious or fatal.

³Idiosyncratic effects

If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.